The invention is in the field of evaporative light scattering detection.
Evaporative light scattering detectors (ELSDs) are used routinely for Liquid Chromatography (LC) analysis. In an ELSD, a liquid sample is converted to droplets by a nebulizer. As the droplets traverse a drift tube, the solvent portion of the droplets evaporates, leaving less volatile analyte. The sample passes to a detection cell, where light scattering of the sample is measured. ELSDs can be used for analyzing a wide variety of samples.
The present inventors identify the nebulizer as a limit on the effectiveness of the detection capabilities of ELSDs. One problem with conventional nebulizers is that complete solvent evaporation does not occur in the drift tube. The expanding trajectory and variable sizes of the droplets produced by conventional nebulizers contributes to the incomplete evaporation and erratic measurement performance. Droplets enter the detection cell and cause scattering that is detected. The scatter effect of droplets is indicated in conventional ELSDs by the fact that substantial scattering is detected in the absence of analytes. This droplet scattering creates a large level of background noise. Accordingly, with typical ELSDs, it is only possible to measure differential scattering, where scattering from the analyte is much greater than that from incompletely volatilized solvent droplets.
Droplets that are too small to carry sufficient analyte are also produced within the distribution of droplets produced by a conventional nebulizer. The small droplets result in analyte particles that are too small to contribute to the detection signal. However, the small droplets increase solvent vapor pressure in the drift tube. Higher vapor pressure retards evaporation in the drift tube. Incomplete evaporation leads to the background noise from scattering caused by droplets as discussed above.
If the droplet size distributions and evaporation rate were constant in the conventional ELSD nebulizers, then the resultant background noise could, to a certain degree, be accounted for in the measurement. However, the rate of incomplete droplet vaporization and their distribution (size and number) tends to change randomly with time. This causes uncertainty in the analyte signal, in addition to the substantial level of background noise.
One conventional strategy for addressing the droplet distribution problem of conventional nebulizers is to remove larger droplets. An impactor has been used in the drift tube of conventional ELSDs to intercept large droplets, which are collected and exit the drift tube through an outlet drain. Additional condensation collects on the walls of the drift tube due to the divergence of spray from the nebulizer, and also drains from the outlet drain. A percentage of the divergent spray that exits via the outlet drain includes properly sized droplets with analyte. Excluding larger droplets produced by a conventional nebulizer proves difficult in practice because the nature of the droplet distribution depends strongly on three factors: mobile phase composition, mobile phase flow rate and carrier gas flow rate. The dependence is highly interactive, which makes the spray hard to control and difficult to model. These undesirable nebulizer characteristics place extraordinary demands on the structural design of ELSD units, making their design very complicated and highly empirical.
A focused droplet nebulizer of the invention produces substantially uniform droplets of a predetermined size. Droplets are pushed out through a small outlet orifice by the contraction of a chamber. The droplets can be carried on a substantially non-divergent path in a drift tube. A piezo membrane micro pump acts in response to an electrical control signal to force a droplet out of the outlet orifice. The nebulizer can operate at frequencies permitting a stream of individual droplets of the predetermined size to be sent along the substantially non-divergent path in the drift tube of a preferred embodiment ELSD device.
The problems inherent with the use of a conventional nebulizer ultimately limit performance in evaporative light scattering detectors (ELSDs). Size, complexity, and cost are also adversely affected by the nebulizer. The invention provides a focused droplet nebulizer. A nebulizer of the invention produces substantially uniform sized droplets. Preferred embodiment nebulizers also provide a precisely controlled droplet production rate and deliver droplets along a focused path. An ELSD of the invention uses a focused droplet nebulizer to reduce background noise and improve the state of ELSD detection.
A preferred embodiment focused droplet nebulizer includes a piezo membrane micro pump. The piezo membrane micro pump has an inlet with a check valve that allows liquid to flow one way into the pump. When the piezo membrane expands, liquid is drawn into the pump and when the piezo membrane contracts, liquid is forced out a tiny outlet orifice. This creates a small single droplet. The check valve ensures that little liquid flows back through the inlet port. The droplet output is strictly controlled by an electrical signal. In other embodiments, a plurality of orifices and/or piezo membrane elements are used to produce parallel droplet streams.
Dimensions of the focused droplet nebulizer are set to produce droplets of a predetermined size. Dimensions may be set, for example, to produce droplets anywhere within in the approximate range of between 10 and 100 μm, which are sizes typically of interest in ELSD systems. Droplets in a particular physical embodiment constructed in accordance with the invention have a very narrow size distribution, typically 5% standard deviation. Applied to an ELSD, substantially all droplets will contribute to the detection signal. The rate of droplet production is controlled independently by electrical signal, e.g. a periodic signal, fed to the micro pump. Thus, the rate of droplet formation can be easily varied so as to optimize the signal to noise ratio. The droplet size is independent of droplet production rate and is not strongly dependent on liquid composition. There is substantially no divergence in the droplet path, typically 1-2 degrees standard deviation. Operation can be independent of the flow rate of the carrier gas. Piezo element micro pumps have a relatively low cost, tolerate a wide range of organic and aqueous liquids, and have a relatively long lifetime.
Preferred embodiments of the invention will now be discussed with reference to the drawings. The particular exemplary devices will be used for purposes of illustration of the invention, but the invention is not limited to the the particular illustrated devices.
The focused droplet nebulizer 104, under control of the controller 107, produces substantially uniformly sized droplets, e.g., droplets having a very narrow size distribution, typically 5% standard deviation. The rate of droplet production is controlled readily by an electrical signal, e.g., a periodic signal, provided to the micro pump by the controller 107. The rate of droplet formation can be varied by the controller 107 to optimize the signal to noise ratio. This can be an automatic optimization provided by the controller 107, or can be an optimization conducted with operator input to the controller 107. Droplet size is independent of droplet production rate and is substantially independent of liquid composition.
The focused droplet nebulizer 104 sends the uniformed sized droplets on a substantially non-divergent focused path, typically 1-2 degrees standard deviation, into the flow of carrier gas down a drift tube 108, which is a heated section of tubing through which gas/droplets flow, and in which evaporation occurs. The mobile phase (solvent) tends to evaporate as the droplet stream passes along drift tube 108. The gas stream enters an optical cell 110, which is the detection module of the unit. The stream passes through the cell 110 and out an exit port 112 as a waste gas steam 114.
The basis of the detection method is the amount of light scattered within the detection cell 110. Ideally, scattering will arise only from substances (analytes) dissolved in the mobile phase and scattering from the mobile phase per se will be negligible. In the ideal case, all mobile phase molecules will be converted to gas in the drift tube 108, and will produce little or no scattering in the optical cell 110. Analytes, if present, will not vaporize but will be left as airborne particles, which produce substantial light scattering as they pass through the optical cell 110. Thus, if the mobile phase 102 contains an analyte, light scattering will be observed within the cell 110, whereas if the mobile phase 102 contains no analyte, little or no light scattering will be observed within the cell 110. With this situation, whenever an analyte exits the LC column, an analyte peak (strong scattering by particles) will be observed above the baseline (weak scattering by solvent).
Evaporation is highly efficient in the ELSD of
Within the focused droplet nebulizer 104, the piezo membrane micro pump 202 receives the mobile phase 102. The mobile phase 102 enters the micro pump 202, which is centrally mounted in a gas manifold 204. Carrier gas 206 enters the manifold 204 and exits into the drift tube 108 in a concentric manner around the micro pump 202. The gas manifold gives a uniform flow of gas to carry the droplets into the drift tube 108. Substantially uniform droplets 210 are produced by the micro pump 202 at a size determined by the micro pump outlet orifice and at a rate determined by the frequency of the signal applied to the micro pump piezo by the controller 107. The droplet path is substantially non-divergent and unidirectional as shown and is carried along by the carrier gas stream 208.
Due to the substantially consistent drop size and substantially non-divergent path, the ELSD of
In the ELSD of
For example, a 100 picoliter (pL) droplet with an 8 kHz signal would require a liquid input flow rate of about 0.05 mL/min, which is much smaller than typical LC liquid flow rates used in a conventional ELSD device. Assuming an unmodified typical LC column 100, only a fraction of the column effluent will be used by the focused droplet nebulizer 104. Sampling the mobile phase effluent can be conducted in a manner that represents the actual composition of the effluent at every instant, and without requiring that the entire volume of effluent pass through the micro pump. Thus, the focused droplet nebulizer 104 can be used with a typical conventional LC column 100 with appropriate sampling, or a modified, lower rate LC column can be used.
Sampling of the effluent for reduced flow into the focused droplet nebulizer 104 can be achieved by various techniques. A structure for reduced flow sampling is shown in
Another structure for reduced flow sampling is shown in
Another structure for reduced flow sampling is shown in
Analyte enters the optical cell 110 after traversing the drift tube 108. The optical cell is shown in
While specific embodiments of the present invention have been shown and described, it should be understood that other modifications, substitutions and alternatives are apparent to one of ordinary skill in the art. Such modifications, substitutions and alternatives can be made without departing from the spirit and scope of the invention, which should be determined from the appended claims.
Various features of the invention are set forth in the appended claims.
Number | Name | Date | Kind |
---|---|---|---|
4426213 | Stavropoulos | Jan 1984 | A |
4958529 | Vestal | Sep 1990 | A |
5529244 | Horvath, Jr. et al. | Jun 1996 | A |
5837826 | Flickinger et al. | Nov 1998 | A |
6024129 | Schima | Feb 2000 | A |
6362880 | Anderson, Jr. et al. | Mar 2002 | B1 |
6750449 | Marcus | Jun 2004 | B2 |
7006218 | Anderson et al. | Feb 2006 | B2 |
20010001575 | Anderson, Jr. et al. | May 2001 | A1 |
20050045239 | Krieger et al. | Mar 2005 | A1 |
20070023037 | Larsen et al. | Feb 2007 | A1 |
Number | Date | Country |
---|---|---|
WO 9932174 | Jul 1999 | WO |
Number | Date | Country | |
---|---|---|---|
20070023037 A1 | Feb 2007 | US |